Relevant articles

Labels: sources manual selection automatic selection

Immune cell subset profiling in multiple sclerosis after fingolimod initiation and continued treatment: The FLUENT study

CONCLUSION: FLUENT provides insights into the utility of immunological profiling to evaluate therapy response and potential infection risk.
Continue Reading

PubMed auto

Identification of disability status in persons with multiple sclerosis by lower limb neuromuscular function - Emphasis on rate of force development

CONCLUSION: Lower extremity neuromuscular function is impaired in pwMS compared to HC with differences (∼deficits) becoming greater with increasing disability status. RFD was preferentially sensitive in capturing differences …
Continue Reading

PubMed auto

A computational modelling study of excitation of neuronal cells with triboelectric nanogenerators

Neurological disorders and nerve injuries, such as spinal cord injury, stroke, and multiple sclerosis can result in the loss of muscle function. Electrical stimulation of the neuronal cells is the currently available clinical …
Continue Reading

PubMed auto

Prediction of relapse activity when switching to cladribine for multiple sclerosis

CONCLUSION: Relapse during or prior to the treatment gap, and younger age, are of prognostic relevance in the year after switching to cladribine. Switching from NTZ is also independently associated with greater relapse hazard.
Continue Reading

PubMed auto

Efficacy of Vafidemstat in Experimental Autoimmune Encephalomyelitis Highlights the KDM1A/RCOR1/HDAC Epigenetic Axis in Multiple Sclerosis

Lysine specific demethylase 1 (LSD1; also known as KDM1A), is an epigenetic modulator that modifies the histone methylation status. KDM1A forms a part of protein complexes that regulate the expression of genes involved in the …
Continue Reading

PubMed manual

Current perspectives on the diagnosis and management of fatigue in multiple sclerosis

INTRODUCTION: Fatigue is a common and debilitating symptom among multiple sclerosis (MS) patients with a prevalence up to 81% and with a considerable impact on quality of life. However, its subjective nature makes it difficult to …
Continue Reading

PubMed auto

Inhibition of astrocytic DRD2 suppresses CNS inflammation in an animal model of multiple sclerosis

Astrocyte activation is associated with progressive inflammatory demyelination in multiple sclerosis (MS). The molecular mechanisms underlying astrocyte activation remain incompletely understood. Recent studies have suggested that …
Continue Reading

PubMed manual

Articles listed here come from the following sites, with keyword searches for Multiple Sclerosis, autoimmune encephalomyelitis, encephalomyelitis, immune tolerance, myelin.

Design photo created by rawpixel.com - www.freepik.com

This is an independent project that runs on the good will of volunteers

You can help by spreading the word or by donating what you can to pay for the server costs.